Kirsten Moysich, PhD
Roswell Park Cancer Institute
Co-Principal Investigator, SPORE
Co-Leader, Project 4, CDP and DRP
Dr. Moysich joined the staff of Roswell Park Cancer Institute in 1998 and was appointed as Professor of Oncology and Full Member in the Department of Cancer Prevention and Control in 2009. She also serves as Professor and Academic Program Chair, Department of Cancer Pathology and Prevention and Professor, Department of Social and Preventive Medicine at the State University of New York at Buffalo.
Dr. Moysich earned her doctoral degree in Epidemiology and Community Health and completed a postdoctoral fellowship in Social and Preventative Medicine at SUNY Buffalo. Dr. Moysich has authored or co-authored more than 100 peer-reviewed journal publications. She is an ad-hoc reviewer for more than 30 journals and has participated in over 20 study sections since 2003. She is currently a permanent member of the National Cancer Institute Subcommittee J – Population and Patient-Orientated Training Review Group. Dr. Moysich serves on numerous national and international advisory committees, including the Scientific Advisory Board for the Sister Study, National Institute of Environmental Health Sciences and the Scientific Advisory Board, Exposure and Human Health Committee, U.S. Environmental Protection Agency. Dr. Moysich maintains an active teaching and mentoring schedule. She has served as the primary or co-mentor of over 30 MS or PhD students since 2000.
Dr. Moysich has taught PTR 525 Cancer Epidemiology since 1998 and gives frequent guest lectures at Roswell Park Cancer Institute and the State University of New York at Buffalo. She is also very involved with the cancer advocacy community and has given numerous local and national presentations on a variety of cancer related topics. Dr. Moysich serves on the faculty of the National Breast Cancer Coalition's Project Lead program and as a Member of the Healthcare Advisory Council of Gilda's Club Western New York.
Dr. Moysich's research interests include immune function in the etiology and prognosis of cancer, molecular epidemiology, ovarian cancer, multiple myeloma, and breast cancer.